ℹ️
🇬🇧
Search
Search for people relevant for "RIBAVIRIN"
RIBAVIRIN
Person
Class
Person
Publication
Programmes
PharmDr. Zuzana Ptáčková Ph.D.
External person at Faculty of Pharmacy in Hradec Králové
16 publications
Publications
publication
Transport of ribavirin across the rat and human placental barrier: roles of nucleoside and ATP-binding cassette drug efflux transporters
2019 |
Faculty of Pharmacy in Hradec Králové
publication
S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is Not a Selective Inhibitor of Equilibrative Nucleoside Transporters but Also Blocks Efflux Activity of Breast Cancer Resistance Protein
2020 |
Faculty of Pharmacy in Hradec Králové
publication
Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics
2019 |
Faculty of Pharmacy in Hradec Králové
publication
Expression of Concentrative Nucleoside Transporters (SLC28A) in the Human Placenta: Effects of Gestation Age and Prototype Differentiation-Affecting Agents
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Equilibrative nucleoside transporter 1 (ENT1, SLC29A1) facilitates transfer of the antiretroviral drug abacavir across the placenta
2018 |
Faculty of Pharmacy in Hradec Králové
publication
MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption
2017 |
Faculty of Pharmacy in Hradec Králové
publication
Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine
2017 |
Faculty of Pharmacy in Hradec Králové
publication
Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine
2016 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs)
2016 |
Faculty of Pharmacy in Hradec Králové
Load more publications (6)
Loading network view...